Insider holders · CIK 0001006281
Protalix BioTherapeutics, Inc. · PLX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Camber Capital Management LLC10% Owner | — | 10,775,000 | 10,775,000 | Dec 6, 2016 · 3:26 pm EST | Form 4 |
| Yoseph ShaaltielExecutive VP, R&D | 585,916 | 210,000 | 795,916 | Sep 16, 2016 · 5:01 pm EDT | Form 4 |
| Yaron NaosSr. VP, Operations | 71,125 | 128,438 | 199,563 | Jun 8, 2018 · 4:07 pm EDT | Form 3 |
| Yossi MaimonVice President & CFO | 10,000 | 185,000 | 195,000 | Dec 15, 2015 · 7:30 am EST | Form 4 |
| Moshe ManorPresident & CEO | 50,000 | — | 50,000 | May 16, 2017 · 9:31 am EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.